Arrowstreet Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Arrowstreet Capital’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-333,607	Closed	-$6.22M	–	1503
2022 Q1	$6.22M	Buy	333,607 +245,478	+279%	+$4.42M	0.01%	594
2021 Q4	$1.89M	Buy	88,129 +70,829	+409%	+$1.4M	﹤0.01%	1030
2021 Q3	$320K	Sell	17,300 -19,000	-52%	-$383K	﹤0.01%	1467
2021 Q2	$777K	Buy	36,300 +13,200	+57%	+$268K	﹤0.01%	1601
2021 Q1	$446K	Buy	+23,100	New	+$407K	﹤0.01%	2024

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arrowstreet Capital's OCDX Position: Q2 2022 in Review

Arrowstreet Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 333,607 shares — an estimated $6.22M sold.

Arrowstreet Capital first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $6.22M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Arrowstreet Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Arrowstreet Capital sold 333,607 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $6.22M.
Arrowstreet Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Arrowstreet Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $6.22M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Arrowstreet Capital's 13F filing for Q2 2022, filed 15 Aug 2022.